{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:34:55Z","timestamp":1787319295739,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.bone.2004.04.021","type":"journal-article","created":{"date-parts":[[2004,7,6]],"date-time":"2004-07-06T19:35:45Z","timestamp":1089142545000},"page":"785-791","source":"Crossref","is-referenced-by-count":40,"title":["High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment"],"prefix":"10.1016","volume":"35","author":[{"given":"G.","family":"Amato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Mazziotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sorvillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Piscopo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Lalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Biondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Molinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Giustina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Carella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2004.04.021_BIB1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2265.1999.00626.x","article-title":"Bone turnover and cortical bone mineral density in the distal radius in patients with hyperthyroidism being treated with antithyroid drugs for various periods of time","volume":"50","author":"Olkawa","year":"1999","journal-title":"Clin. Endocrinol"},{"key":"10.1016\/j.bone.2004.04.021_BIB2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/BF03345061","article-title":"Bone turnover in hyperthyroidism before and after thyrostatic management","volume":"23","author":"Isaia","year":"2000","journal-title":"J. Endocrinol. Invest"},{"key":"10.1016\/j.bone.2004.04.021_BIB3","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1210\/jc.85.3.1099","article-title":"Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism","volume":"85","author":"Pantazi","year":"2000","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.bone.2004.04.021_BIB4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2265.2002.01578.x","article-title":"Bone remodelling markers and serum cytokines in patients with hyperthyroidism","volume":"57","author":"Akalin","year":"2002","journal-title":"Clin. Endocrinol"},{"key":"10.1016\/j.bone.2004.04.021_BIB5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1210\/jc.84.2.435","article-title":"Serum cytokines in thyrotoxicosis","volume":"84","author":"Siddiqi","year":"1999","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.bone.2004.04.021_BIB6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bone.2004.04.021_BIB7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bone.2004.04.021_BIB8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1083\/jcb.145.3.527","article-title":"The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts","volume":"145","author":"Burgess","year":"1999","journal-title":"J. Cell Biol"},{"key":"10.1016\/j.bone.2004.04.021_BIB9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/er.20.3.345","article-title":"Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families","volume":"20","author":"Suda","year":"1999","journal-title":"Endocr. Rev"},{"key":"10.1016\/j.bone.2004.04.021_BIB10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s001090100226","article-title":"Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology","volume":"79","author":"Hofbauer","year":"2001","journal-title":"J. Mol. Med"},{"key":"10.1016\/j.bone.2004.04.021_BIB11","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1006\/bbrc.1998.8697","article-title":"Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor\/osteoprotegerin","volume":"247","author":"Mizuno","year":"1998","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.bone.2004.04.021_BIB12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1359\/jbmr.1999.14.4.518","article-title":"Immunological characterization of circulating osteoprotegerin\/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis","volume":"14","author":"Yano","year":"1999","journal-title":"J. Bone Miner. Res"},{"key":"10.1016\/j.bone.2004.04.021_BIB13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1359\/jbmr.2001.16.2.348","article-title":"The effect of a single dose of osteoprotegerin in postmenopausal women","volume":"16","author":"Bekker","year":"2001","journal-title":"J. Bone Miner. Res"},{"key":"10.1016\/j.bone.2004.04.021_BIB14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1530\/eje.0.1450685","article-title":"Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess\u2014Possible role in bone homeostasis","volume":"145","author":"Ueland","year":"2001","journal-title":"Eur. J. Endocrinol"},{"key":"10.1016\/j.bone.2004.04.021_BIB15","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1210\/jc.2003-030088","article-title":"Serum osteoprotegerin in adolescent girls with anorexia nervosa","volume":"88","author":"Misra","year":"2003","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.bone.2004.04.021_BIB16","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/00002281-200307000-00013","article-title":"Mechanisms of glucocorticoid-induced osteoporosis","volume":"15","author":"Canalis","year":"2003","journal-title":"Curr. Opin. Rheumatol"},{"key":"10.1016\/j.bone.2004.04.021_BIB17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1530\/eje.0.1450681","article-title":"Serum measurement of osteoprotegerin\u2014Clinical relevance and potential applications","volume":"145","author":"Hofbauer","year":"2001","journal-title":"Eur. J. Endocrinol"},{"key":"10.1016\/j.bone.2004.04.021_BIB18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/01.ATV.0000012303.37971.DA","article-title":"RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function","volume":"22","author":"Schoppet","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1016\/j.bone.2004.04.021_BIB19","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/01.CIR.0000031524.49139.29","article-title":"Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease","volume":"106","author":"Jono","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2004.04.021_BIB20","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/art.10388","article-title":"High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment","volume":"46","author":"Ziolkowska","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bone.2004.04.021_BIB21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(03)14073-1","article-title":"Hyperthyroidism","volume":"362","author":"Cooper","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2004.04.021_BIB22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0020-7292(98)00113-1","article-title":"Reproducibility and diagnostic sensitivity of ultrasonometry of the phalanges to assess osteoporosis","volume":"63","author":"Reginster","year":"1998","journal-title":"Int. J. Gynaecol. Obstet"},{"key":"10.1016\/j.bone.2004.04.021_BIB23","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1359\/jbmr.2000.15.8.1603","article-title":"Phalangeal osteosonogrammetry study: age-related changes, diagnostic sensitivity, and discrimination power. The Phalangeal Osteosonogrammetry Study Group","volume":"15","author":"Wuster","year":"2000","journal-title":"J. Bone Miner. Res"},{"key":"10.1016\/j.bone.2004.04.021_BIB24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1210\/jc.84.1.90","article-title":"Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease","volume":"84","author":"Costagliola","year":"1999","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.bone.2004.04.021_BIB25","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S8756-3282(03)00090-5","article-title":"Normative values of bone metabolism serum levels of osteoprotegerin increase with age in a healthy adult population","volume":"32","author":"Kudlacek","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.04.021_BIB26","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00223-003-0033-5","article-title":"Triiodothyronine (T3) and 1, 25-dihydroxyvitamin D3 (1, 25D(3)) inversely regulate OPG gene expression in dependence of osteoblastic phenotype","volume":"74","author":"Varga","year":"2004","journal-title":"Calcif. Tissue Int"},{"key":"10.1016\/j.bone.2004.04.021_BIB27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF03040334","article-title":"Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status","volume":"115","author":"Fahrleitner-Pammer","year":"2003","journal-title":"Wien. Klin. Wochenschr"},{"key":"10.1016\/j.bone.2004.04.021_BIB28","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/jcb.10242","article-title":"Detection and characterization of RANK ligand and osteoprotegerin in the thyroid gland","volume":"86","author":"Hofbauer","year":"2002","journal-title":"J. Cell. Biochem"},{"key":"10.1016\/j.bone.2004.04.021_BIB29","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJM199712043372307","article-title":"The thyrotropin receptor in thyroid diseases","volume":"337","author":"Paschke","year":"1997","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.bone.2004.04.021_BIB30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0092-8674(03)00771-2","article-title":"TSH is a negative regulator of skeletal remodelling","volume":"115","author":"Abe","year":"2003","journal-title":"Cell"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328204001784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328204001784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T01:25:01Z","timestamp":1549416301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328204001784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S8756328204001784"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2004.04.021","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}